Clinical Trial Update: Entresto Tablets and Granules for Pediatric Specified Drug-use Survey (Pediatric Chronic Heart Failure)

View source ↗

Summary

A clinical trial update for Entresto (sacubitril/valsartan) tablets and granules evaluating pediatric chronic heart failure; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Entresto (sacubitril/valsartan)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Pediatric Chronic Heart Failure | Status: RECRUITING